Anna Kole

554 total citations
10 papers, 333 citations indexed

About

Anna Kole is a scholar working on Genetics, Physiology and Neurology. According to data from OpenAlex, Anna Kole has authored 10 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 3 papers in Physiology and 2 papers in Neurology. Recurrent topics in Anna Kole's work include Genomics and Rare Diseases (6 papers), Biomedical Ethics and Regulation (3 papers) and BRCA gene mutations in cancer (3 papers). Anna Kole is often cited by papers focused on Genomics and Rare Diseases (6 papers), Biomedical Ethics and Regulation (3 papers) and BRCA gene mutations in cancer (3 papers). Anna Kole collaborates with scholars based in France, United Kingdom and Sweden. Anna Kole's co-authors include François Faurisson, Pauline McCormack, Deborah Mascalzoni, Simon Woods, Hanns Lochmüller, Sabina Gainotti, Olaf Rieß, Franz Schaefer, Mats Hansson and Bartha Maria Knoppers and has published in prestigious journals such as Frontiers in Pharmacology, Advances in experimental medicine and biology and European Journal of Human Genetics.

In The Last Decade

Anna Kole

8 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Kole France	8	153	134	65	58	43	10	333
Pauline McCormack United Kingdom	9	170 1.1×	113 0.8×	77 1.2×	58 1.0×	41 1.0×	19	350
Peter Goodhand Canada	6	166 1.1×	206 1.5×	35 0.5×	99 1.7×	44 1.0×	8	400
Anne Marie Tassé Canada	12	274 1.8×	141 1.1×	137 2.1×	52 0.9×	54 1.3×	19	396
Nicole C. Lockhart United States	10	210 1.4×	116 0.9×	110 1.7×	124 2.1×	49 1.1×	16	425
Marianna J. Bledsoe United States	9	234 1.5×	74 0.6×	126 1.9×	52 0.9×	49 1.1×	21	320
Sirpa Soini Finland	11	138 0.9×	93 0.7×	75 1.2×	64 1.1×	28 0.7×	20	372
Kristin Solum Steinsbekk Norway	8	255 1.7×	59 0.4×	139 2.1×	53 0.9×	39 0.9×	10	391
Sabrina A. Suckiel United States	13	142 0.9×	323 2.4×	32 0.5×	92 1.6×	36 0.8×	23	467
Denise Lautenbach United States	9	114 0.7×	363 2.7×	48 0.7×	60 1.0×	53 1.2×	10	499
Alice K. Hawkins Canada	10	275 1.8×	112 0.8×	149 2.3×	79 1.4×	62 1.4×	11	454

Countries citing papers authored by Anna Kole

Since Specialization

Citations

This map shows the geographic impact of Anna Kole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kole more than expected).

Fields of papers citing papers by Anna Kole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kole. The network helps show where Anna Kole may publish in the future.

Co-authorship network of co-authors of Anna Kole

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kole. A scholar is included among the top collaborators of Anna Kole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kole. Anna Kole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kole, Anna, et al.. (2022). Valuing the “Burden” and Impact of Rare Diseases: A Scoping Review. Frontiers in Pharmacology. 13. 914338–914338. 28 indexed citations

Díaz‐Manera, Jordi, et al.. (2022). Impact of restricted access to, and low awareness of, mexiletine on people with myotonia: a real-world European survey. Neuromuscular Disorders. 33(2). 208–217.

McCormack, Pauline, Anna Kole, Sabina Gainotti, et al.. (2016). ‘You should at least ask’. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research. European Journal of Human Genetics. 24(10). 1403–1408. 65 indexed citations

Gainotti, Sabina, Catherine Turner, Simon Woods, et al.. (2016). Improving the informed consent process in international collaborative rare disease research: effective consent for effective research. European Journal of Human Genetics. 24(9). 1248–1254. 35 indexed citations

Aartsma‐Rus, Annemieke, Janbernd Kirschner, Anna Kole, et al.. (2015). TREAT-NMD (translational research in Europe, assessment and treatment for neuromuscular disorders). Neuromuscular Disorders. 25. S271–S271.

Mascalzoni, Deborah, Edward S. Dove, Yaffa Rubinstein, et al.. (2014). International Charter of principles for sharing bio-specimens and data. European Journal of Human Genetics. 23(6). 721–728. 104 indexed citations

Graham, Caroline, Hugh Dawkins, Gareth Baynam, et al.. (2014). Current trends in biobanking for rare diseases: a review. UWA Profiles and Research Repository (University of Western Australia). 49–49. 16 indexed citations

McCormack, Pauline & Anna Kole. (2014). Setting up strategies: patient inclusion in biobank and genomics research in Europe. Orphanet Journal of Rare Diseases. 9(Suppl 1). P2–P2. 7 indexed citations

Kole, Anna & François Faurisson. (2010). Rare Diseases Social Epidemiology: Analysis of Inequalities. Advances in experimental medicine and biology. 686. 223–250. 67 indexed citations

10.

Kole, Anna & Yann Le Cam. (2010). The added value of centres of expertise for rare disease patients in Europe. Orphanet Journal of Rare Diseases. 5(S1). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact